Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-8603
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study ; volume:16 ; number:1 ; day:10 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Globalization and health ; 16, Heft 1 (10.9.2020), 1-11, 12.2020
- Klassifikation
-
Wirtschaft
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12992-020-00610-2
- URN
-
urn:nbn:de:101:1-2020103019134731339191
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jung, Ye Lim
- Hwang, JeeNa
- Yoo, Hyoung Sun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA
A Content Analysis of Whistleblowing Policies of Leading European Companies
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA
A Content Analysis of Whistleblowing Policies of Leading European Companies
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA